11
AUG
2014

Efficacy and Safety of adding Fenofibrate 160 mg in high-risk patients with mixed hyperlipidemia not controlled by Pravastatin 40 mg monotherapy

Posted By :
Comments : Off

Farnier, Ducobu, Bryniarski, Efficacy and Safety of adding Fenofibrate 160 mg in high-risk patients with mixed hyperlipidemia not controlled by Pravastatin 40 mg monotherapy, American Journal of Cardiology, May 2010
https://www.ajconline.org/article/S0002-9149(10)01041-6/fulltext

https://download.journals.elsevierhealth.com/pdfs/journals/0002-9149/PIIS0002914910010416.pdf

About the Author